drugset / Trial / NCT02812342

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

NCT02812342

Phase 2 Completed 10 enrolled Yale University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate the use of topical tofacitinib to promote hair regrowth in patients with alopecia areata, alopecia totalis, and alopecia universalis.

Timeline

Start
2016-09
Primary completion
2018-07
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tofacitinib Small molecule Topical